Predictive value of interferon regulatory factor 5 nuclear translocation in B cells for disease activity and flare in systemic lupus erythematosus: A prospective observational cohort study
Modern Rheumatology · 04.11.2026 · 36 (6) · 988-997
DOI: 10.1093/mr/roag024 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Modern Rheumatology, online erschienen am 13.03.2026. Verfasst von Yoshiro Kanayama und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Interferon Regulatory Factors, B-Lymphocytes, Cell Nucleus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Objectives
This study aimed to determine whether interferon regulatory factor 5 (IRF5) activation and its temporal dynamics in immune cells correlate with disease activity and flares in patients with systemic lupus erythematosus (SLE).
Methods
Patients with SLE were prospectively enrolled and followed up for 52 weeks. The IRF5 nuclear translocation rate (NTR) was assessed in monocytes, dendritic cells, and B cells during baseline and follow-ups. Associations among IRF5 NTR, disease activity, and flares were statistically analyzed.
Results
Of the 40 patients enrolled, 27 were included in the analysis after meeting all inclusion criteria. Baseline IRF5 NTR in B cells was correlated with SLE disease activity index scores (r = 0.529, P = .005). Nineteen patients developed flares, and a high baseline IRF5 NTR showed good predictive accuracy (AUC = 0.763) and an increased flare risk (OR = 25.5, P = .003). In survival analysis, patients with a high IRF5 NTR had significantly shorter flare-free survival (log-rank P = .030) and a higher hazard of flare (HR = 7.43, P = .010). The IRF5 NTR further increased during the 12 weeks preceding flares (P = .040).
Conclusion
The IRF5 NTR in B cells is a potential biomarker for disease activity and flare prediction in SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
- Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
- Center for Rheumatic Diseases, Mie University Hospital, Tsu, Japan.
- Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.
ORCID-Profile: Yoshiro Kanayama, Tatsuma Ban, Kunihiro Yamaoka, Tomohiko Tamura
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Kanayama, Y., Ban, T., Sato, G. R., Arinuma, Y., Matsueda, Y., Yamaoka, K., & Tamura, T. (2026). Predictive value of interferon regulatory factor 5 nuclear translocation in B cells for disease activity and flare in systemic lupus erythematosus: A prospective observational cohort study. Modern Rheumatology, 36(6), 988-997. https://doi.org/10.1093/mr/roag024
Vancouver
Kanayama Y, Ban T, Sato GR, Arinuma Y, Matsueda Y, Yamaoka K, et al. Predictive value of interferon regulatory factor 5 nuclear translocation in B cells for disease activity and flare in systemic lupus erythematosus: A prospective observational cohort study. Modern Rheumatology. 2026;36(6):988-997. doi:10.1093/mr/roag024
BibTeX
@article{Kanayama2026,
author = {Kanayama, Yoshiro and Ban, Tatsuma and Sato, Go R and Arinuma, Yoshiyuki and Matsueda, Yu and Yamaoka, Kunihiro and Tamura, Tomohiko},
title = {Predictive value of interferon regulatory factor 5 nuclear translocation in B cells for disease activity and flare in systemic lupus erythematosus: A prospective observational cohort study},
journal = {Modern Rheumatology},
year = {2026},
volume = {36},
number = {6},
pages = {988--997},
doi = {10.1093/mr/roag024}
}
EUVIMED